By Jason Overdorf A $400 million market for clinical trials puts desperate Indian patients at risk. CHENNAI, India — India’s huge population, many of whom have hardly been exposed to medication, makes it one of the world’s most promising markets for drug research. But as the $400 million business accelerates, critics say it is exposing […]
Flacking for Big Pharma
By Harriet Washington Drugmakers don’t just compromise doctors; they also undermine top medical journals and skew medical research. “Drug Makers Cut Out Goodies for Doctors” and “Drugmakers Pulling Plug on Free Pens, Mugs & Pads” read headlines in The New York Times and The Wall Street Journal Health Blog at the end of 2008 after, […]
Are big drug firms cashing in on vaccine aid billions?
By Daniel Berman, of Médecins Sans Frontières MSF (Doctors Without Borders) who worked in the drug industry. It is amazing the GAVI conference has been a success. The number of kids being vaccinated will dramatically increase. And it is equally amazing that in the current climate the UK Government made this commitment. But I’m worried […]
Virus in the system
By Natasha Bita KIRSTEN and Mick Button were looking forward to a family holiday in Bali when the letter landed in their mailbox. From the West Australian Health Department, it urged them to vaccinate their children against the flu. A killer new strain of influenza, a mutant mix of human, avian and swine influenza viruses, […]
Beware the ghost(writer)s of medical research
By Dr. Marc-André Gagnon and Dr. Sergio Sismondo, Expert Advisors – EvidenceNetwork.ca OTTAWA, and KINGSTON, ON, June 16, 2011/ Troy Media/ – The medical research world has been concerned about the problem of ghostwriting for more than a decade. The issue has been repeatedly raised in the mainstream media over the past few years, with […]
- « Previous Page
- 1
- …
- 261
- 262
- 263
- 264
- 265
- …
- 575
- Next Page »
